Yamashita Satoshi, Tawara Nozomu
Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Methods Mol Biol. 2019;1901:89-94. doi: 10.1007/978-1-4939-8949-2_7.
Sporadic inclusion body myositis (sIBM) is a chronic and progressive inflammatory myopathy that is the commonest among population over 50s. Recently, autoantibodies against cytosolic 5'-nucleotidase 1A (cN1A) have been identified in plasma and serum samples from patients with sIBM. So far, various methods have been established to detect the anti-cN1A autoantibodies, which showed a clinical utility of detection of the autoantibodies in the diagnosis of sIBM. Here we describe a novel cell-based assay for detection of the autoantibodies, which seems equivalent in sensitivity and better in specificity for the diagnosis of sIBM, compared with the previous methods.
散发性包涵体肌炎(sIBM)是一种慢性进行性炎性肌病,在50岁以上人群中最为常见。最近,在sIBM患者的血浆和血清样本中发现了针对胞质5'-核苷酸酶1A(cN1A)的自身抗体。到目前为止,已经建立了多种方法来检测抗cN1A自身抗体,这些方法显示出在sIBM诊断中检测自身抗体的临床实用性。在此,我们描述了一种用于检测自身抗体的新型细胞检测方法,与先前的方法相比,该方法在诊断sIBM时似乎具有相同的敏感性和更好的特异性。